Evaluating microvascular invasion in hepatitis B virus-related hepatocellular carcinoma based on contrast-enhanced computed tomography radiomics and clinicoradiological factors

doi:10.3748/wjg.v30.i45.4801

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (826)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

552

Figures (1-5)

Tables (1-2)

Sum=717

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=83

Dec 7, 2024 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Dec 7, 2024; 30(45): 4801-4816
Published online Dec 7, 2024. doi: 10.3748/wjg.v30.i45.4801

Full Size Figure Download Figure

Figure 1 Flow diagram of the study enrolment patients. HBsAg: Hepatitis B surface antigen; HBcAb: Anti-hepatitis B core antigen antibodies; HCC: Hepatocellular carcinoma; CECT: Contrast-enhanced computed tomography.

Citation: Xu ZL, Qian GX, Li YH, Lu JL, Wei MT, Bu XY, Ge YS, Cheng Y, Jia WD. Evaluating microvascular invasion in hepatitis B virus-related hepatocellular carcinoma based on contrast-enhanced computed tomography radiomics and clinicoradiological factors. World J Gastroenterol 2024; 30(45): 4801-4816
URL: https://www.wjgnet.com/1007-9327/full/v30/i45/4801.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i45.4801